New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
09:58 EDTSPEXSpherix, Fullife Healthcare sign supply and license agreement
Spherix Incorporated and Fullife Healthcare announced the signing of a supply and license agreement for the use of D-tagatose in nutraceutical products in India. Under the terms of the agreement, Spherix has granted Fullife an exclusive, royalty-bearing license in India for use of Spherix's clinical data and proprietary know-how to support marketing and dosing of the D-tagatose that Spherix will also be supplying. The D-tagatose will be used in food or cosmetic products that may provide health benefits in return for a fixed royalty on gross sales. Spherix will provide bulk D-Tagatose to Fullife and Fullife will be responsible for all testing and development of products containing D-Tagatose for sale in India. Financial terms of the agreement were not disclosed.
News For SPEX From The Last 14 Days
Check below for free stories on SPEX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 13, 2014
10:37 EDTSPEXSpherix to host business news update conference call
Subscribe for More Information
August 11, 2014
15:45 EDTSPEXSpherix subsidiary settles with AT&T, files joint motion to dismiss
Spherix (SPEX) subsidiary Guidance IP has reached a settlement with AT&T (T), according to a court document filed August 7 in the U.S. District Court for the Northern District of Texas. The settlement stems from a lawsuit filed on December 6, 2013 by Spherix for infringement of its patent entitled, "System and Method for Determining the Geolocation of a Transmitter." Shares of small-cap Spherix are up 19% to $1.75 in later afternoon trading following the circulation of the court filing. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use